Stephan Nowatschin (Co-Founer, CEO) and Maximilian Krinninger (Co-Founder, CTO) Louisa Summer
What inspired you to found your startup?
The market of surgical robotics is characterized by complex, stand-alone systems, which are reserved for surgeries with high numbers of cases and high reimbursement rates. We came up with the idea of a cost-effective, modular platform that scales easily to a wide range of applications.
How are you different? What is your unique value proposition?
We are the first company worldwide that offers a modular robotic platform for surgery. All our solutions are set up in a few seconds, directly at the operating table, and are ready for immediate use. Due to their slim design, they have a small footprint and are compatible with existing instrumentation.
How do you define success for yourself and your company?
We will be successful when we become an established key player in the surgical robotics market, and when our approach is known and used worldwide for a variety of clinical applications benefitting a broad number of patients and surgeons every day.
What do you want to achieve next year?
We want to greatly expand our sales activities. In addition to Europe and the Middle East, we want to serve the North American market in particular. We also plan to enhance our technology platform with additional robots. In order to do this, we will do a Series-B financing in the end of Q1/2019.
Why do people want to work at your company?
We wanted to create the perfect working infrastructure to enable each employee to devote its individual strengths fully to the fascinating topic of surgical robotics. Our company depends on each individual, and everyone has the opportunity to visibly contribute to our mission.
What has been the most important milestone so far?
With Brainlab, a leading medical technology company, we were able to gain an established and strong strategic partner. On the one hand, our approach and technology were positively evaluated. On the other hand, it enabled us to gain market access to neurosurgery and spine surgery.
Looking back at your whole development story — what makes you most proud?
After quitting our well-paid jobs in the medical industry, we started with a piece of paper and an idea, and were lucky to find investors who believed in us – even though we had no prototype. This was extraordinary, especially for Germany and this industry.
Where do you see your company in 5 years?
The company has established itself in the world market, and a significant number of surgeons and patients in the field of ENT and skull base surgery are benefitting from the advantages of our products. Other surgical disciplines have also adopted our technology platform.
What is your impression of launching a startup from your based city?
Munich has an excellent infrastructure, and it accommodates many highly qualified people who appreciate the high recreational value of the region. At the same time, there is a high level of competition for the best minds among the many well-known large corporations in the city and its surrounding area.
What is your impression of the german startup scene? Would you change anything?
The German startup scene profits from the many existing incubators and startup networks, where interested founders can find support. As a result, the barriers for foundations of high-tech startups were reduced. It would be good if the many startups were presented more often in public by the media.
Medineering was featured in “The Hundert Vol. 10 – Startups of Germany“, November 2018.